Address
Email address
Phone number
https://rosena.eeKollageen | Näohooldus | Akne ravi tooted | Juuste vitamiinid - RosenaApteegikosmeetika ja toidulisandid Euroopa tootjatelt. Meie valikus on akne ravi tooted, kollageeni toidulisandid, psoriaasi ja atoopilise dermatiidi kreemid, toidulisandid lastele, juuste vitamiinid jpm.
Name
OÜ Rosena DK
Registry code
14002345
VAT number
EE101862516
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
25.02.2016 (8)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46451 - Wholesale of perfume and cosmetics 47911 - Retail sale via mail order houses or via Internet
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Anniki Telling 03.09.1964 (60) | 50% - 1 250.00 EUR | Board member | Direct ownership | Founder |
| Karin Telling 19.01.1984 (40) | 50% - 1 250.00 EUR | Board member | Direct ownership | Founder |
| Ivar Järving 13.07.1957 (67) | - | - | - | Founder |
| Nigulas Samel 03.09.1950 (74) | - | - | - | Founder |
| 2019 23.04.2021 | 2020 30.06.2021 | 2021 05.10.2022 | 2022 31.08.2023 | |
|---|---|---|---|---|
| Total Revenue | 437 026 € | 538 502 € | 567 644 € | 422 188 € |
| Net profit (loss) for the period | 16 885 € | 52 896 € | 1 511 € | 5 109 € |
| Profit Margin | 4% | 10% | 0% | 1% |
| Current Assets | 109 259 € | 137 577 € | 177 978 € | 155 810 € |
| Fixed Assets | 43 647 € | 41 421 € | 28 857 € | 20 804 € |
| Total Assets | 152 906 € | 178 998 € | 206 835 € | 176 614 € |
| Current Liabilities | 185 654 € | 165 992 € | 124 732 € | 95 905 € |
| Non Current Liabilities | 13 087 € | 5 945 € | 73 532 € | 67 029 € |
| Total Liabilities | 198 741 € | 171 937 € | 198 264 € | 162 934 € |
| Share Capital | - | - | - | - |
| Equity | -45 835 € | 7 061 € | 8 571 € | 13 680 € |
| Employees | 4 | 4 | 4 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 128 739.2 € | 14 388.76 € | 5 285.84 € | 4 |
| 2023 Q4 | 125 362.77 € | 11 689.95 € | 3 966.74 € | 4 |
| 2023 Q3 | 112 191.33 € | 11 920.99 € | 4 137.9 € | 3 |
| 2023 Q2 | 174 187.64 € | 17 633.69 € | 4 690.82 € | 3 |
| 2023 Q1 | 108 388.42 € | 15 177.6 € | 5 382.7 € | 3 |
| 2022 Q4 | 130 251.02 € | 17 059.3 € | 9 559.18 € | 4 |
| 2022 Q3 | 147 426.97 € | 21 635.48 € | 7 831.6 € | 5 |
| 2022 Q2 | 131 794.45 € | 15 845.55 € | 6 545.41 € | 5 |
| 2022 Q1 | 169 805.31 € | 17 934.63 € | 9 812.08 € | 6 |
| 2021 Q4 | 175 677.17 € | 21 919 € | 9 137.2 € | 6 |
| 2021 Q3 | 175 665.21 € | 15 866.57 € | 8 226.86 € | 7 |
| 2021 Q2 | 227 279.72 € | 14 301.31 € | 8 834.35 € | 6 |
| 2021 Q1 | 182 254.54 € | 23 367.41 € | 6 996.17 € | 6 |
| 2020 Q4 | 261 015.81 € | 21 259.36 € | 6 210.44 € | 6 |
| 2020 Q3 | 131 020.34 € | 12 769.74 € | 3 525.95 € | 5 |
| 2020 Q2 | 172 234.54 € | 13 312.12 € | 5 177.55 € | 5 |
| 2020 Q1 | 170 687.9 € | 19 874.39 € | 4 897.24 € | 6 |
